VP Inflammation & Immunology (all genders)
VP Inflammation & Immunology (all genders)
VP Inflammation & Immunology (all genders)
VP Inflammation & Immunology (all genders)
Evotec
Bio- und Nanotechnologie
Göttingen
- Art der Anstellung: Vollzeit
- Vor Ort
- Zu den Ersten gehören
VP Inflammation & Immunology (all genders)
Über diesen Job
The Head of Inflammation & Immunology (I&I) is a senior scientific and strategic leadership role responsible for shaping and executing the R&D strategy within the I&I therapeutic area. Reporting to the Head of Therapeutic Areas, this role drives innovation, identifies high-impact opportunities, and steers cross-functional efforts to build a competitive and differentiated pipeline. The role operates in a matrix environment, influencing internal and external stakeholders to position Evotec as a leader in the field.
Key Responsibilities
Strategic Leadership & Scientific Direction
Define and lead the scientific strategy for the therapeutic area, aligned with Evotec’s R&D and business objectives.
Identify emerging opportunities based on scientific trends, competitive landscape, and unmet medical needs.
Champion the therapeutic area’s vision internally and externally, ensuring scientific excellence and innovation.
Own the R&D budget and ROI for the therapeutic area, including internal projects and strategic collaborations.
Prioritize and oversee early-stage R&D initiatives, from target identification to preclinical development.
Provide scientific leadership and collaborate with Operations, Key Account Management and Business Development to identify, shape, and convert R&D projects into partnerships.
Represent Evotec’s expertise at customer events, scientific conferences, consortia, and in peer-reviewed publications.
Knowledge & Experience
PhD or equivalent in a relevant life science discipline
Minimum 10 years of experience, with solid strategical and technical understanding of the pharma R&D value chain and project deliverables with in-depth subject matter expertise in the I&I space
Drug discovery experience from target ID to PDC of at least 10 years, exposure to planning of clinical development and trials up to PoC’s desirable
Proven track record in progressing discovery-stage programs and strategic collaborations
Experience in licensing, partnering, and external scientific representation
Strong network and credibility in the I&I field
Skills & Competencies
Strategic and systems thinker with a future-oriented mindset
Strong leadership and influencing skills in a matrix environment
Excellent communication and stakeholder engagement abilities
Ability to integrate scientific, commercial, and operational perspectives
Experience in omics data interpretation would be a plus
Skilled in building communities and fostering cross-functional alignment
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 5,000 highly qualified people. The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence. For additional information please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn.
Please click on the link below to access and review our Privacy Information for Applicants:
Privacy Information for Applicants
Unternehmens-Details
Evotec
Bio- und Nanotechnologie